Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,071.2
6.7 (0.22%)

 

  • STI Straits Times Index
    3,071.2
    6.7 (0.22%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,548.5
    -6.8 (-0.43%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,920.8
    252.9 (1.03%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,614.0
    6.9 (0.19%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    30,500.0
    176.7 (0.58%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,133.2
    23.3 (0.38%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,452.5M
  • Value: 2,581.7M
  • Rise: 161
  • Fall: 177
  • Unch: 416

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Hatten Land0.073+0.013
ESR-REIT0.475-0.010
OUE Com Reit0.445-
Sembcorp Marine0.084+0.001
StarhillGbl Reit0.630-0.005
ARA LOGOS Log Tr0.935+0.010
GSS Energy0.077+0.005
Lippo Malls Tr0.054+0.003
Singtel2.430+0.030
CapLand IntCom T2.000-0.020

World Indices

World Indices
Name Last Change
Nasdaq 15,044.0 -138.0
HSI 24,920.8 +252.9
HSCEI 8,940.5 +134.7
Jakarta 6,133.2 +23.3
Nikkei 225 30,500.0 +176.7
SSE Comp 3,614.0 +6.9
Shanghai A 3,787.7 +7.3
Shanghai B 273.1 -1.8
KOSPI 3,140.5 +10.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

RESMED INC RESMED
Updated on 17 Sep 2021 (End of trading day)
Last (USD): 285.950 Change: -0.230 High: 287.860 Remarks: -
Change (%): -0.08 Low: 284.000
Open 284.990 Yesterday's Close 286.18
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 917,479 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 3.25715 Trailing EPS (USD) e 3.25715 NAV (USD) b 19.8082
PE a 87.791 Trailing PE f 87.791 Price / NAV b 14.4359
Dividend (USD) d 1.559651 Cash In Hand (USD) g 2.0269 Issued & Paid-up Shares c 145,681,000
Dividend Yield (%) d 0.545 Price / Cash In Hand g 141.078 Treasury Shares h 41,836,234
Market Cap (M) 41,657.482 Enterprise Value (M) 42,155.919
Piotroski F Score 4 Exchange Code RMD Par Value ( $ ) n.a.
52 Weeks Volatility (%) 25.97 Free Float (%) -
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 18 Aug 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 26 Oct 2018.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference RESMED INC NYSE 41,657.482 87.791 87.791 14.4359 0.545
Industry Medical Specialties NYSE 44,781.332 49.166 35.600 4.9776 0.583
Local Peer DANAHER CORP NYSE 231,681.967 66.006 66.006 5.8671 0.221
Local Peer ABBOTT LABORATORIES NYSE 224,775.848 50.252 35.420 6.6502 1.206
Local Peer THERMO FISHER SCIENTIFIC INC NYSE 234,792.459 36.830 27.314 6.3709 0.149
Local Peer MEDTRONIC PLC NYSE 174,551.557 48.406 44.953 3.3903 1.865
Local Peer STRYKER CORP NYSE 102,958.521 64.389 49.428 7.4500 0.860
Local Peer BECTON DICKINSON & CO NYSE 75,229.420 98.083 40.337 3.1173 1.234
Local Peer EDWARDS LIFESCIENCES CORP NYSE 74,437.830 90.403 50.901 14.5010 -
Local Peer BOSTON SCIENTIFIC CORP NYSE 63,176.224 - 134.992 3.9629 -
Local Peer AGILENT TECHNOLOGIES INC NYSE 52,655.639 73.235 53.188 10.6461 0.419
Local Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 43,136.101 31.878 32.200 3.0433 2.168
Local Peer ALCON AG NYSE 42,144.698 - 230.299 2.2107 0.124
Local Peer BAXTER INTERNATIONAL INC NYSE 41,797.475 37.929 37.319 4.9208 1.154
Other Local Peers METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), WATERS CORP (NYSE), BIO RAD LABORATORIES INC (NYSE), COOPER COS INC (NYSE), STERIS PLC (NYSE), PERKINELMER INC (NYSE), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), QIAGEN NV (NYSE), PENUMBRA INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), NEVRO CORP (NYSE), CONMED CORP (NYSE), HAEMONETICS CORP (NYSE), GLAUKOS CORPORATION (NYSE), BUTTERFLY NETWORK INC (NYSE), AVANOS MEDICAL INC (NYSE), CRYOLIFE INC (NYSE), VAPOTHERM INC (NYSE), INVACARE CORP (NYSE)
Global Peer INTUITIVE SURGICAL INC NASDAQ 123,425.795 116.374 76.067 11.3888 -
Global Peer ALIGN TECHNOLOGY INC NASDAQ 56,839.293 32.006 81.379 16.7944 -
Global Peer IDEXX LABORATORIES INC NASDAQ 56,295.574 96.765 77.345 75.3159 -
Global Peer DEXCOM INC NASDAQ 54,483.176 110.379 102.682 27.2743 -
Global Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 28,321.690 38.925 70.211 8.7692 -
Global Peer INSULET CORPORATION NASDAQ 20,142.172 2,962.119 - 43.8732 -
Global Peer HOLOGIC INC NASDAQ 19,678.196 17.645 9.657 5.0755 -
Global Peer ABIOMED INC NASDAQ 16,109.971 71.433 104.331 12.3210 -
Global Peer MASIMO CORPORATION NASDAQ 15,110.366 62.881 67.550 10.8611 -
Global Peer DENTSPLY SIRONA INC NASDAQ 13,381.878 - 36.334 2.6373 0.654
Other Global Peers NOVOCURE LTD (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), BRUKER CORPORATION (NASDAQ), COCHLEAR LTD (ASX), MICROPORT (HKEx), SHOCKWAVE MEDICAL INC (NASDAQ), WEIGAO GROUP (HKEx), TANDEM DIABETES CARE INC (NASDAQ), ANGELALIGN (HKEx), SOTERA HEALTH CO (NASDAQ), STAAR SURGICAL CO (NASDAQ), Top Glove (SGX), TOPGLOV (Bursa), QUIDEL CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), INMODE LTD (NASDAQ), HARTA (Bursa), ICU MEDICAL INC (NASDAQ), NEOGEN CORP (NASDAQ), LIVANOVA PLC (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), EBOS GROUP (ASX), MERIT MEDICAL SYSTEMS (NASDAQ), INARI MEDICAL INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), CAREDX INC (NASDAQ), ATRICURE INC (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), AXONICS INC (NASDAQ), NUVASIVE INC (NASDAQ), HESKA CORP (NASDAQ), OUTSET MEDICAL INC (NASDAQ), VENUS MEDTECH-B (HKEx), CELLDEX THERAPEUTICS INC (NASDAQ), VERICEL CORP (NASDAQ), LIFETECH SCI (HKEx), CARDIOFLOW-B (HKEx), SILK ROAD MEDICAL INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), PEIJIA-B (HKEx), IRHYTHM TECHNOLOGIES INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), ZYLOXTB-B (HKEx), KANGJI MEDICAL (HKEx), SUPERMX (Bursa), INOVIO PHARMACEUTICALS INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), AK MEDICAL (HKEx), PROCEPT BIOROBOTICS CORP (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), PULMONX CORPORATION (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), NANOSONICS LIMITED (ASX), ORTHOPEDIATRICS CORP (NASDAQ), SIGHT SCIENCES INC (NASDAQ), ATRION CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), NANO-X IMAGING LTD (NASDAQ), INOGEN INC (NASDAQ), VIEWRAY INC (NASDAQ), CERUS CORP (NASDAQ), ANGIODYNAMICS INC (NASDAQ), DERMTECH INC (NASDAQ), 908 DEVICES INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), MODERN DENTAL (HKEx), CIRC (HKEx), TRANSMEDICS GROUP INC (NASDAQ), CUTERA INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), EARGO INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), SISRAM MED (HKEx), BIOVENTUS INC (NASDAQ), SURMODICS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SI BONE INC (NASDAQ), INTERCURE LTD (NASDAQ), CHUNLI MEDICAL (HKEx), NYXOAH SA (NASDAQ), KDL MEDICAL (HKEx), AXOGEN INC (NASDAQ), PAVMED INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), ANTARES PHARMA INC (NASDAQ), ACOTEC-B (HKEx), SEASPINE HOLDINGS CORP (NASDAQ), HEARTCARE-B (HKEx), FLUIDIGM CORP DEL (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), AVITA MEDICAL INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SOLITON INC (NASDAQ), METRICS INCOME OPPORTUNITIES TRUST (ASX), BASECARE-B (HKEx), MISONIX INC (NASDAQ), IRADIMED CORP (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), NEUROPACE INC (NASDAQ), ZYNEX INC (NASDAQ), STEREOTAXIS INC (NYSE American), CLEARPOINT NEURO INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), ACUTUS MEDICAL INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), SIENTRA INC (NASDAQ), ONCOCYTE CORP (NASDAQ), CONFORMIS INC (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), UTAH MEDICAL PRODUCTS (NASDAQ), CVRX INC (NASDAQ), YESTAR HEALTH (HKEx), ACCURAY INCORPORATED (NASDAQ), ICECURE MEDICAL LTD (NASDAQ), LUCIRA HEALTH INC (NASDAQ), PROFOUND MED CORP (NASDAQ), QUOTIENT LTD (NASDAQ), AROA BIOSURGERY LTD (ASX), APOLLO ENDOSURGERY INC (NASDAQ), CLARITY PHARMACEUTICALS LTD (ASX), MYMD PHARMACEUTICALS INC (NASDAQ), PW MEDTECH (HKEx), MEDICAL DEVELOPMENT INTL (ASX), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), DARIOHEALTH CORP (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), INTRICOM CORP (NASDAQ), UGHealthcare (SGX), TELA BIO INC (NASDAQ), Medtecs Intl (SGX), TITAN MEDICAL INC (NASDAQ), CORMEDIX INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), NEURONETICS INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), NEMAURA MEDICAL INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), SOMNOMED LIMITED (ASX), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), CYCLOPHARM LIMITED (ASX), IMPEDIMED LIMITED (ASX), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), VENUS CONCEPT INC (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), FONAR CORP (NASDAQ), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), ALPHA PRO TECH (NYSE American), IRIDEX CORP (NASDAQ), ELECTROMED INC (NYSE American), OPTISCAN IMAGING (ASX), KELFRED (HKEx), CRYO-CELL INTERNATIONAL INC (NASDAQ), MICRO-X LTD (ASX), BIOLASE INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CHECK-CAP LTD (NASDAQ), NEPHROS INC (NASDAQ), CELSION CORPORATION (NASDAQ), SDI LTD (ASX), LENSAR INC (NASDAQ), VINCENT MED (HKEx), VOLITIONRX LIMITED (NYSE American), ZOSANO PHARMA CORP (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), AVINGER INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), SOLENO THERAPEUTICS INC (NASDAQ), IMMUCELL CORP (NASDAQ), ELECTROCORE INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), RGTBHD (Bursa), PREDICTIVE ONCOLOGY INC (NASDAQ), APPLIED UV INC (NASDAQ), NEUROMETRIX INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), SENSUS HEALTHCARE INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), YUNNAN ENERGY (HKEx), IMAGION BIOSYSTEMS LIMITED (ASX), BIOMERICA INC (NASDAQ), NEOVASC INC (NASDAQ), COMPUMEDICS (ASX), ADVENTA (Bursa), DIMERIX LTD (ASX), NANOVIBRONIX INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), DAXOR CORP (NYSE American), CARDIEX LTD (ASX), LKL (Bursa), NOVA EYE MEDICAL LIMITED (ASX), RESPIRI LTD (ASX), INSPIREMD INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), Yunnan Energy (SGX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), RESONANCE HEALTH LTD (ASX), TENAX THERAPEUTICS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), LBT INNOVATIONS LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), PETVIVO HLDGS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), Biolidics (SGX), ADHERIUM LIMITED (ASX), VIVEVE MEDICAL INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), DYNATRONICS CORP (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), RA MEDICAL SYSTEMS INC (NYSE American), XTANT MEDICAL HLDGS INC (NYSE American), OVENTUS MEDICAL LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), CYANOTECH CORP (NASDAQ), LIFE HEALTHCARE (HKEx), OSPREY MEDICAL INC NPV DFD 23/09/21(EX-SPLIT) (ASX), NUWELLIS INC (NASDAQ), METALICITY LIMITED (ASX), USCOM LTD (ASX), TRUSCREEN GROUP LTD (ASX), STAR EQUITY HOLDINGS INC (NASDAQ), Annica (SGX), HUAKANG BIOMED (HKEx), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --9.640
-3.26 %
10 Days --9.850
-3.33 %
20 Days -+0.260
+0.09 %
Medium Term Return 3 Months -+48.510
+20.43 %
6 Months -+100.350
+54.07 %
1 Year 37.050+115.940
+89.99 %
Long Term Return 2 Years 99.450+151.420
+186.48 %
3 Years 100.950+172.120
+239.89 %
5 Years 103.710+222.700
+516.06 %
Annualised Return Annualised --
+43.86 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 165.721 - 301.340 Change From 1 Year Low +120.229 % Change From 1 Year Low (%) +72.55
Change From 1 Year High -15.390 % Change From 1 Year High (%) -5.11
2 Years Range 108.850 - 301.340 Change From 2 Years Low +177.100 % Change From 2 Years Low (%) +162.70
Change From 2 Years High -15.390 % Change From 2 Years High (%) -5.11
5 Years Range 56.590 - 301.340 Change From 5 Years Low +229.360 % Change From 5 Years Low (%) +405.30
Change From 5 Years High -15.390 % Change From 5 Years High (%) -5.11
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the following segments: Sleep and Respiratory Care, and Software as a Service. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment engages in the supply of business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
17 Sep 2021 284.990 287.860 284.000 285.950 917,479 -
16 Sep 2021 289.260 289.260 282.520 286.180 621,112 -
15 Sep 2021 291.830 292.560 288.950 290.420 416,687 -
14 Sep 2021 289.710 293.790 289.010 292.280 454,527 -
13 Sep 2021 296.790 297.620 287.495 288.900 537,260 -
10 Sep 2021 297.330 298.080 294.598 295.590 539,769 -
09 Sep 2021 298.600 301.340 295.305 295.580 347,912 -
08 Sep 2021 292.800 298.300 291.670 297.360 462,462 -
07 Sep 2021 296.170 296.770 292.170 296.010 473,347 -
03 Sep 2021 292.160 296.430 290.880 295.800 245,479 -
02 Sep 2021 289.570 294.510 289.470 294.400 301,235 -
01 Sep 2021 288.410 289.620 283.474 288.070 552,182 -
31 Aug 2021 290.020 290.730 287.320 290.530 520,256 -
30 Aug 2021 285.900 290.780 285.540 289.060 342,827 -
27 Aug 2021 286.160 289.050 285.175 286.910 297,821 -
26 Aug 2021 285.230 285.900 282.970 285.040 250,497 -
25 Aug 2021 282.300 286.140 281.585 285.560 331,709 -
24 Aug 2021 285.630 287.085 282.000 282.240 367,433 -
23 Aug 2021 287.960 290.260 285.530 285.840 371,862 -
20 Aug 2021 281.730 287.880 281.000 285.690 422,605 -
19 Aug 2021 279.000 286.220 277.950 283.030 304,425 -
18 Aug 2021 280.500 283.170 279.430 279.570 345,549 -
Summary
Current 2 Weeks
(03 Sep 2021 to 17 Sep 2021)
292.160 301.340 282.520 285.950 5,016,034 -
Previous 2 Weeks
(20 Aug 2021 to 02 Sep 2021)
281.730 301.340 281.000 294.400 3,758,427 -
4 Weeks from
(23 Jul 2021 to 19 Aug 2021)
258.170 301.340 257.730 283.030 9,190,429 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.